Michael Grimm

Mr. Michael Grimm


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2022 in Current Treatment Options in Oncology
Verified
Journal Article
Closed access
PDF file
JMJessica N. Mezzanotte
Jessica N. Mezzanotte
MGMichael Grimm
Michael Grimm
NSNamrata V. Shinde
Namrata V. Shinde
TNTimiya S. Nolan
Timiya S. Nolan
LWLise Worthen-Chaudhari
Lise Worthen-Chaudhari
MLMaryam Lustberg
Maryam Lustberg

Verified
Journal Article
Open access
PDF file
MGMichael Grimm
Michael Grimm
LRLindsey Radcliff
Lindsey Radcliff
MGMariann Giles
Mariann Giles
RNRyan Nash
Ryan Nash
EHErin Holley
Erin Holley
APAshley Pariser
Ashley Pariser
Survivors of advanced breast cancer (ABC), also known as metavivors, are often left with fewer treatment options in the landscape of a cure culture. Metavivors have unique psychosocial and physical needs distinct from patients with early-stage breast cancer. This analysis delves into side effects commonly experienced by patients with ABC, such as fatigue, anxiety, and cardiotoxicity; how these side effects impact caregiver support, financial toxicity, emotional strain, and spiritual and emotional distress; as well as current strategies for mitigation, including nutrition, exercise, and participation in clinical research. Overall, this analysis is a mandate for additional research to explore novel treatments and implement strategies to maintain and improve patients’ quality of life.